Anna Protopapas

Anna Protopapas

Chairman at NUVALENT, INC.

Net worth: 1 M $ as of 29/04/2024

59 year
Health Technology
Consumer Services
Finance

Anna Protopapas active positions

CompaniesPositionStartEnd
MERSANA THERAPEUTICS, INC. Director/Board Member 01/03/2015 -
Chief Executive Officer 01/03/2015 09/09/2023
President 01/03/2015 09/09/2023
NUVALENT, INC. Chairman 29/03/2022 -
Independent Dir/Board Member 29/03/2022 -

Career history of Anna Protopapas

Former positions of Anna Protopapas

CompaniesPositionStartEnd
DICERNA PHARMACEUTICALS, INC. Director/Board Member 22/01/2019 02/06/2021
Independent Dir/Board Member 22/01/2019 02/06/2021
BIOVERATIV INC Director/Board Member 27/02/2017 07/03/2018
ARIAD PHARMACEUTICALS, INC. Director/Board Member 31/03/2015 15/01/2017
Independent Dir/Board Member 31/03/2015 15/01/2017
Chief Executive Officer 04/07/2013 30/09/2014
Corporate Officer/Principal 30/09/1997 04/07/2013
President 04/07/2013 30/09/2014
Corporate Officer/Principal 28/07/2011 30/09/2014
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal 30/09/2010 30/09/2014
Director/Board Member - -

Training of Anna Protopapas

Princeton University Undergraduate Degree
Massachusetts Institute of Technology Graduate Degree
Stanford Graduate School of Business Masters Business Admin

Statistics

International

United States 12
Japan 2

Operational

Director/Board Member 5
Corporate Officer/Principal 3
Independent Dir/Board Member 3

Sectoral

Health Technology 8
Consumer Services 3
Finance 2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies3
TAKEDA PHARMACEUTICAL COMPANY LIMITED

Health Technology

MERSANA THERAPEUTICS, INC.

Health Technology

NUVALENT, INC.

Health Technology

Private companies6

Health Technology

Process Industries

Commercial Services

Health Technology

Health Technology

Health Technology

See company connections